Pfizer Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shows how much money the company made and spent in the last three months.
Announces earnings and performance numbers that tell investors how the business is doing.
Company confirms its expected $59.5-$62.5 billion revenue and $2.80-$3.00 earnings per share targets.
Leadership change affects who manages the company's money and financial decisions.
Shows how much money the company made and spent in the first three months.
Announces earnings and performance numbers that tell investors how the business is doing.
Board members elected to run the company; includes Scott Gottlieb and Cyrus Taraporevala.
Stocky reads Pfizer Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Pfizer Inc.'s most recent tracked filing was a 10-Q on 4 Aug 2026: Files quarterly financial report for second quarter 2026.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.